Two HLA-A2- and HLA-24-restricted CD8 T-cell epitopes of GPC3 have been mapped in mice and shown to elicit T-cell responses in HCC patients after long-term in vitro stimulation of PBMCs [34]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.